Document Detail

The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.
MedLine Citation:
PMID:  1624679     Owner:  NLM     Status:  MEDLINE    
We analyzed the evolution of the ophthalmopathy associated with Graves' hyperthyroidism in 45 patients treated with two different antithyroid drug regimens. Group A patients (n = 31) received either methimazole (40-100 mg daily) or propylthiouracil (400-900 mg daily) combined with T3 daily throughout treatment. Group B patients (n = 14) were treated with conventional regimen with lower doses of either methimazole (5-25 mg daily) or propylthiouracil (50-300 mg daily) and no T3 addition. Eye signs and proptosis measurement were evaluated just before the beginning of the treatment and compared with the results after antithyroid drug withdrawal. Improvement of the eye signs considered on grounds of the NOSPECS classification was greater in group A than group B (p less than 0.01). Also, the decrease in proptosis measurement was greater (p less than 0.01) in patients treated with combined regimen (21.5 +/- 2.4 mm to 20.4 +/- 2.3 mm) than in patients receiving conventional therapy (20.4 +/- 1.6 mm to 20.0 +/- 1.7 mm). Serum thyroglobulin concentrations did not correlate with either the severity or the evolution of the ophthalmopathy. Negative serum antithyroglobulin antibody (TgAb) was associated with the improvement of the ophthalmopathy that was noted in 24 out of 27 patients (Chi-Square = 5.84; p less than 0.001). Thus, serum TgAb levels might have some connection with progression of eye signs but serum Tg concentration does not. Our study suggests that in most patients the transition from hyperthyroidism to euthyroidism induced by antithyroid drug therapy is associated with the improvement of the Graves' ophthalmopathy. However, no marked difference can be drawn between the two treatment regimens.
N Bromberg; J H Romaldini; R S Werner; J A Sgarbi; M C Werner
Related Documents :
11747279 - Use of cold iodine in patients with graves' disease: observations from a clinical pract...
24516789 - Therapeutic impact of organism isolation in management of patients with pyogenic verteb...
2741719 - Extended long-term drug monotherapy of graves' disease.
11676109 - Role of surgery in the management of graves' disease.
11240989 - Salivary flow dynamics after parotid surgery: a preliminary report.
24935319 - Selecting oversized donor cardiac allografts for patients with pulmonary hypertension m...
11391149 - Reasons for failure of glyceryl trinitrate treatment of chronic fissure-in-ano: a multi...
12142899 - Changes in soft tissue profile after orthodontic treatment with and without extractions.
8989009 - Prevention of spinal anesthesia-induced hypotension in the elderly: comparison between ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  15     ISSN:  0391-4097     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  1992 Mar 
Date Detail:
Created Date:  1992-08-11     Completed Date:  1992-08-11     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  191-5     Citation Subset:  IM    
Department of Endocrinology, Hospital Servidor Publico Estadual de Sao Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Autoantibodies / blood
Drug Therapy, Combination
Eye Diseases / blood,  drug therapy*,  etiology
Graves Disease / blood,  complications,  drug therapy*
Methimazole / administration & dosage*
Middle Aged
Propylthiouracil / administration & dosage*
Thyroglobulin / blood,  immunology
Triiodothyronine / administration & dosage*
Reg. No./Substance:
0/Autoantibodies; 51-52-5/Propylthiouracil; 60-56-0/Methimazole; 6893-02-3/Triiodothyronine; 9010-34-8/Thyroglobulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
Next Document:  Corticosterone methyloxydase deficiency type II in a Croatian girl.